Billionaire Harvard Professor’s Fortune Jumps Nearly $200 Million On News Of Eli Lilly Biotech Deal

Shares of biotech firm Morphic Holding, founded by Harvard immunologist Tim Springer, rocketed up 75% Monday after Eli Lilly said it would snap it up for $3.2 billion.